Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2020 Nov 5;10(1):19132.
doi: 10.1038/s41598-020-75666-6.

Dual antiplatelet therapy reduced stroke risk in transient ischemic attack with positive diffusion weighted imaging

Affiliations
Observational Study

Dual antiplatelet therapy reduced stroke risk in transient ischemic attack with positive diffusion weighted imaging

Lu-Lu Pei et al. Sci Rep. .

Abstract

Dual antiplatelet therapy (DAPT) reduced stroke risk in high-risk transient ischemic attack (TIA) patients assessed by ABCD2 score. Patients with positive diffusion-weighted imaging (DWI) were identified as imaging-based high-risk. The present study aims to investigate whether DAPT could reduce stroke risk in TIA with DWI positive. The study enrolled TIA patients within 72 h of onset from the prospective TIA database of the First Affiliated Hospital of Zhengzhou University. The predictive outcome was ischemic stroke at 90-day. The relationship between DAPT and stroke was analyzed in a cox proportional hazards model. The Kaplan-Meier curves of TIA patients with DAPT and monotherapy were plotted. Total of 661 TIA patients were enrolled, 279 of whom were DWI positive and 281 used DAPT. The 90-day stroke risk was higher in patients used monotherapy than those used DAPT in TIA with positive DWI (23.7% vs. 13.4%, p = 0.029). DAPT was associated with reduced stroke risk in TIA patients with positive DWI (hazard ratio [HR] = 0.54; 95% confidence interval [CI], 0.30-0.97; p = 0.037). However, the benefit didn't exist in TIA patients with negative DWI (HR = 0.43; 95% CI, 0.14-1.33; p = 0.142). Early use of DAPT reduced stroke risk in TIA patients with positive DWI.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Flow diagram of the eligible TIA patients. A total of 827TIA patients within 72 h of onset were prospectively enrolled from October 2010 to June 2015. Excluded were 46 with unavailable DWI information, 59 with endovascular therapy or surgery, 46 without antiplatelet therapy, 15 patients lost-to follow-up at 90 days. In patients with DWI positive, 127 patients (45.5%) used DAPT therapy. And in patients with DWI negative, 154(40.3%) patients used DAPT therapy.
Figure 2
Figure 2
Cumulative probability of ischemic stroke in TIA patients with monotherapy and DAPT by DWI patterns. In TIA patients with DWI positive, there was a significant difference in the 90-day stroke rate between DAPT and monotherapy (log-rank test = 4.994, p = 0.025, A). However, the difference was not statistical significance in patients with DWI negative (log-rank test = 2.106, p = 0.147, B).

Similar articles

Cited by

References

    1. Johnston SC, et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N. Engl. J. Med. 2018;379:215–225. doi: 10.1056/NEJMoa1800410. - DOI - PMC - PubMed
    1. Wang Y, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N. Engl. J. Med. 2013;369:11–19. doi: 10.1056/NEJMoa1215340. - DOI - PubMed
    1. Yi X, et al. Antiplatelet drug resistance is associated with early neurological deterioration in acute minor ischemic stroke in the Chinese population. J. Neurol. 2016;263:1612–1619. doi: 10.1007/s00415-016-8181-5. - DOI - PubMed
    1. Kennedy J, et al. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol. 2007;6:961–969. doi: 10.1016/S1474-4422(07)70250-8. - DOI - PubMed
    1. Johnston SC, et al. Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design. Int. J. Stroke. 2013;8:479–483. doi: 10.1111/ijs.12129. - DOI - PMC - PubMed

Publication types

MeSH terms